Healthcare Services

Opioid Use Disorder (OUD) Market Revenue Growth Expected to Reach $7.82 Billion by 2030 with 12.5% CAGR

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Opioid Use Disorder (OUD) Market Across 2026–2030?

The opioid use disorder (OUD) market has expanded quickly in recent years. It is projected to increase from $4.37 billion in 2025 to $4.89 billion in 2026, with an 11.8% compound annual growth rate (CAGR). This growth observed in the past can be ascribed to several factors, including the overprescription of opioid painkillers, a rising prevalence of chronic pain conditions, restricted access to early addiction treatment, the social stigma associated with substance abuse treatment, and the growing availability of illicit opioids.

The opioid use disorder (OUD) market is expected to experience significant expansion in the next few years, projected to reach $7.82 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is influenced by several factors, including increased government funding for addiction treatment initiatives, broader acceptance of medication-assisted treatment, the proliferation of online and telehealth addiction services, expanded insurance coverage for OUD therapies, and an intensified focus on preventive and harm reduction strategies. Key trends for the forecast period include the increasing adoption of medication-assisted treatment programs, enhanced integration of behavioral therapy with pharmacological care, the expansion of community-based opioid treatment centers, a rising focus on long-acting injectable therapies for OUD, and a greater emphasis on relapse prevention and long-term recovery support.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Primary Drivers Are Shaping The Development Of The Opioid Use Disorder (OUD) Market?

The escalating number of opioid addiction cases is projected to stimulate the expansion of the opioid use disorder (OUD) market. Opioid addiction is characterized as a medical condition involving the compulsive and prolonged use of opioids, resulting in adverse bodily effects. Opioids offer sensations of euphoria and pain relief, yet their continuous consumption can lead to the development of tolerance, requiring larger doses for the same impact, which can then progress into opioid use disorder. For example, in 2023, the Centers for Disease Control and Prevention, a US-based public health agency, reported 79,358 drug overdose deaths involving any opioid. The rate of drug overdose deaths involving any opioid per 100,000 population was 23.7. Thus, the increasing frequency of opioid addiction cases is a key driver for the growth of the opioid use disorder (OUD) market.

What Segmentation Levels Are Considered In The Opioid Use Disorder (OUD) Market?

The opioid use disorder (oud) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route Of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

Which Market Trends Are Creating New Opportunities In The Opioid Use Disorder (OUD) Market?

Companies prominent in the opioid use disorder (OUD) market are prioritizing the creation of innovative solutions, such as advanced extended-release buprenorphine formulations. This effort is in response to the increasing demand for long-acting, adherence-promoting treatment alternatives that alleviate withdrawal symptoms and enhance recovery results. Extended-release buprenorphine formulations offer continuous medication delivery for weekly or monthly durations, providing enhanced convenience and stability compared to daily oral or sublingual therapies, which could potentially raise the risk of relapse. For example, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, granted approval to Brixadi (buprenorphine) extended-release injection for addressing moderate to severe opioid use disorder (OUD). Brixadi is supplied in two forms: a weekly injection for patients who started treatment with a single dose of a transmucosal buprenorphine product or are currently using the medication, and a monthly version for individuals already receiving the drug.

Which Leading Firms Are Contributing To The Growth Of The Opioid Use Disorder (OUD) Market?

Major companies operating in the opioid use disorder (oud) market are Indivior Plc., Alkermes Inc., Braeburn Pharmaceuticals Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo US Inc., Rhodes Pharmaceuticals L P, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Mylan NV, Adapt Pharma Inc., Opiant Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd., Cipla Limited, Luye Pharma Group, Amneal Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Knight Therapeutics, BioCorRx Inc., Lannett Company Inc., Zydus Cadila, Apotex Inc., Intas Biopharmaceuticals, Glenmark Pharmaceuticals Ltd., InterveXion Therapeutics

Read the full opioid use disorder (oud) market report here:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

How Does The Opioid Use Disorder (OUD) Market Perform Across Major Global Regions?

North America was the largest region in the opioid use disorder (OUD) market in 2025. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Opioid Use Disorder (OUD) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2026, By The Business Research Company

Ophthalmic Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report

Ophthalmology Drugs Market

https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market

Ophthalmic Eye Dropper Global Market Report

https://www.thebusinessresearchcompany.com/report/ophthalmic-eye-dropper-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795